J.N. Octave
Impact in
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- S100 Proteins and Annexins 1
- Physiology 10
- Alzheimer's disease research and treatments 9
- Co-authors
- Henri Beaufay (1 shared paper)Mariette Robbi (1 shared paper)Pascal Kienlen‐Campard (5 shared papers)Emmanuel Hermans (3 shared papers)Jean‐Pierre Brion (3 shared papers)Martine I. Darville (1 shared paper)Louis Hue (1 shared paper)Mark H. Rider (1 shared paper)
- Journals
- Journal of Biological Chemistry (3 papers)FEBS Letters (3 papers)Biochemical and Biophysical Research Communications (1 paper)Experimental Gerontology (1 paper)Nucleosides Nucleotides & Nucleic Acids (1 paper)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
J.N. Octave
17 papers receiving 363 citations
Peers
Comparison fields: 5 of 63
- Biochemistry 40
- Pharmacology 80
- Physiology 100
- Cancer Research 57
- Molecular Biology 236
Countries citing papers authored by J.N. Octave
This map shows the geographic impact of J.N. Octave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.N. Octave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.N. Octave more than expected).
Fields of papers citing papers by J.N. Octave
This network shows the impact of papers produced by J.N. Octave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.N. Octave. The network helps show where J.N. Octave may publish in the future.
Co-authors
The 25 scholars most cited alongside J.N. Octave, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 90 | |
| 2 | 1987 | 68 | |
| 3 | 2005 | 40 | |
| 4 | 1990 | 30 | |
| 5 | 2000 | 25 | |
| 6 | 1993 | 22 | |
| 7 | 2013 | 20 | |
| 8 | 1994 | 19 | |
| 9 | The amyloid peptide precursor in Alzheimer's disease. | 1995 | 18 |
| 10 | 2015 | 11 | |
| 11 | 2000 | 10 | |
| 12 | 1996 | 6 | |
| 13 | 2003 | 4 | |
| 14 | 1988 | 4 | |
| 15 | 2001 | 4 | |
| 16 | 2004 | 2 | |
| 17 | [The precursor of amyloid peptide in Alzheimer disease: a protein with multiple functions]. | 2009 | 1 |
About J.N. Octave
J.N. Octave is a scholar working on Molecular Biology, Physiology, Pharmacology, Cellular and Molecular Neuroscience and Epidemiology, having authored 17 papers that have together received 374 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Neuroscience and Neuropharmacology Research (2 papers), Computational Drug Discovery Methods (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Folate and B Vitamins Research (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Biochemistry (40 citations), Pharmacology (80 citations), Physiology (100 citations), Cancer Research (57 citations) and Molecular Biology (236 citations). J.N. Octave has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Henri Beaufay, Mariette Robbi, Pascal Kienlen‐Campard, Emmanuel Hermans, Jean‐Pierre Brion, Martine I. Darville, Louis Hue, Mark H. Rider, M. J. Marchand and Jo Van Damme. Their work appears in journals such as Journal of Biological Chemistry, FEBS Letters, Biochemical and Biophysical Research Communications, Experimental Gerontology and Nucleosides Nucleotides & Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.